Interpretive criteria for disk diffusion susceptibility testing of sparfloxacin

  • F. H. Kayser
  • J. Wüst
Notes

Abstract

Sparfloxacin disk susceptibility test criteria for the NCCLS and ICS/DIN methods were determined by testing 400 bacterial wild-type isolates. Disks containing 5 µg of the drug could be used satisfactorily in both procedures. The following interpretive zone size breakpoints for the NCCLS and ICS/DIN methods were proposed: ≤18 and 20 mm respectively for resistance (MIC>1 mg/l), and ≥23 and 25 mm respectively for susceptibility (MIC≤0.5 mg/l). These criteria were based on preliminary maximum serum concentrations of approximately 1.5 mg/l after a single oral dose of 400 mg of the drug. Regression equations for both methods correlating MICs and zone sizes based on test results for 361 organisms are presented. The equations allow calculation of breakpoints for higher or lower serum peak levels. Sparfloxacin was two to four times more active than ciprofloxacin against gram-positive cocci, and showed equal activity against gram-negative rods. Zone diameter quality control values forEscherichia coli ATCC 25922 were 26–30 mm (NCCLS) and 30–33 mm (ICS/DIN), and forStaphylococcus aureus ATCC 29213 27–28 mm (NCCLS) and 29–31 mm (ICS/DIN).

Keywords

Zone Size Sparfloxacin Zone Diameter Maximum Serum Concentration Serum Peak Level 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Sakaguchi S, Kashimoto H, Yoshida T, Kojima T, Ohue K, Fujimoto M, Nakamura M, Hashimoto M, Shimizu M In vitro and in vivo antibacterial activities of AT-4140, a new broadspectrum quinolone. Antimicrobial Agents and Chemotherapy 1989, 33: 1167–1173.PubMedGoogle Scholar
  2. 2.
    National Committee for Clinical Laboratory Standards Performance standards for antimicrobial disk susceptibility tests — fourth edition. Approved standard. Document M2-A4. NCCLS, Villanova, PA, 1990.Google Scholar
  3. 3.
    Ericson HM, Sherris JC Antibiotic sensitivity testing. Report of an international collaborative study. Acta Pathologica and Microbiologica Scandinavia 1971, 217, Supplement: 1–90.Google Scholar
  4. 4.
    Deutsches Institut für Normung Methoden zur Empfindlichkeitsprüfung von bakteriellen Krankheitserregern (außer Mykobakterien) gegen Chemotherapeutika. DIN 58940, Teil 3. Agar-Diffusionstest. Beuth-Verlag, Berlin, 1981.Google Scholar
  5. 5.
    National Committee for Clinical Laboratory Standards Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically — second edition. Approved Standard. Document M7-A2. NCCLS, Villanova, PA, 1990.Google Scholar

Copyright information

© Friedr. Vieweg & Sohn Verlagsgesellschaft mbH 1991

Authors and Affiliations

  • F. H. Kayser
    • 1
  • J. Wüst
    • 1
  1. 1.Institute of Medical MicrobiologyUniversity of ZurichZurichSwitzerland

Personalised recommendations